menu search

Evelo Biosciences Provides Clinical Updates

Evelo Biosciences Provides Clinical Updates
– Topline Data from fourth cohort of EDP1815 Phase 2 trial in atopic dermatitis did not meet primary endpoint –– Company will focus on development of extracellular vesicles (EVs) –– First EV candidate, EDP2939, in Phase 2 moderate psoriasis study fully enrolled; data anticipated in early Q4 2023 –– Management to host conference call today […] The post Evelo Biosciences Provides Clinical Updates appeared first on ForexTV... Read More
Posted: Apr 26 2023, 11:30
Author Name: forextv
Views: 102267

Search within

Pages Search Results: